
Aurobindo Pharma gets final FDA nod for tofacitinib tablets which target rheumatoid arthritis
The tablets will be manufactured at APL Healthcare unit IV, a wholly-owned subsidiary of the company, and will be launched immediately. Shares of Aurobindo Pharma…








